Arch Therapeutics Introduces Experienced Directors and Executive Leadership CAMBRIDGE, MA--(Marketwired - Jul 2, 2013) -  Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...